EW
Edwards Lifesciences Corp
NYSE: EW · HEALTHCARE · MEDICAL DEVICES
$81.22
-1.29% today
Updated 2026-04-29
Market cap
$46.83B
P/E ratio
43.90
P/S ratio
7.43x
EPS (TTM)
$1.85
Dividend yield
—
52W range
$72 – $88
Volume
5.0M
Edwards Lifesciences Corp (EW) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+7.3%
Last 4 quarters
Revenue YoY growth
+16.7%
Most recent quarter
EPS YoY growth
+21.9%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+2.1%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+3.3%
2026-02-10
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-04-23 | $0.78 | +14.4% | $81.53 | $84.15 | +3.2% |
| 2026-02-10 | $0.58 | -6.4% | $76.80 | $79.33 | +3.3% |
| 2025-10-30 | $0.67 | +13.6% | $82.69 | $82.45 | -0.3% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | $0.68 | $0.78 | +14.4% | $1.65B | +16.7% |
| 2025-12-31 | $0.62 | $0.58 | -6.4% | $1.57B | +13.3% |
| 2025-09-30 | $0.59 | $0.67 | +13.6% | $1.55B | +14.7% |
| 2025-06-30 | $0.62 | $0.67 | +7.5% | $1.53B | +10.6% |
| 2025-03-31 | $0.60 | $0.64 | +7.5% | $1.41B | +6.2% |
| 2024-12-31 | $0.55 | $0.59 | +6.4% | $1.39B | +9.4% |
| 2024-09-30 | $0.64 | $0.67 | +4.7% | $1.35B | +8.9% |
| 2024-06-30 | $0.69 | $0.70 | +1.4% | $1.39B | — |
| 2024-03-31 | $0.64 | $0.66 | +3.1% | $1.33B | — |
| 2023-12-31 | $0.64 | $0.64 | +0.0% | $1.27B | — |
| 2023-09-30 | $0.59 | $0.59 | +0.0% | $1.24B | — |
Analyst EPS and revenue estimates for upcoming years
| Period | EPS estimate | Revenue estimate | Revenue growth | Analysts | Confidence |
|---|---|---|---|---|---|
| 2026 (E) | $3.01 | $6.9B | +13.4% | 21 | high |
| 2027 (E) | $3.37 | $7.5B | +9.8% | 21 | high |
| 2028 (E) | $3.75 | $8.2B | +9.2% | 21 | medium |
| 2029 (E) | $4.12 | $9.0B | +8.7% | 21 | medium |
| 2030 (E) | $4.51 | $9.7B | +8.3% | 21 | medium |
Frequently asked questions
Has Edwards Lifesciences Corp beaten earnings estimates?
Edwards Lifesciences Corp has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +7.3% over the last 4 quarters.
How does EW stock react to earnings?
EW stock has moved an average of +2.1% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Edwards Lifesciences Corp's revenue growth rate?
Edwards Lifesciences Corp reported year-over-year revenue growth of +16.7% in its most recent quarter, with EPS growing +21.9% year-over-year.
What is the expected EPS for EW in 2026?
Analysts expect Edwards Lifesciences Corp to report EPS of $3.01 for fiscal year 2026, on revenue of $6.9B, based on estimates from 21 analysts.